Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients

Nephron - Clinical Practice

Volumn 113, Issue 3, 2009, Pages

  Mitrogianni, Zoi ^a   Barbouti, Alexandra ^a   Galaris, Dimitrios ^a   Siamopoulos, Kostas C ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Albumin carbonylation; Chronic kidney disease; Hemodialysis; Oxidative stress; Peritoneal dialysis

Indexed keywords

ALBUMIN; CARBONYL DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARBONYLATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BIOLOGICAL MARKERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PROTEIN CARBONYLATION; RENAL DIALYSIS; YOUNG ADULT;

EID: 68749097387     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235244     Document Type: Article

References (37)

1. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N: Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056.
2. Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R: The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 2007; 28: 478-483.
3. Baigent C, Burbury K, Wheeler D: Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152.
4. Bergesio F, Monzani G, Guasparini A, Ciuti R, Gallucci M, Cristofano C, Castrignano E, Cupisti A, Barsotti G, Marcucci R, Abbate R, Bandini S, Gallo M, Tosi PL, Salvadori M: Cardiovascular risk factors in severe chronic renal failure: The role of dietary treatment. Clin Nephrol 2005; 64: 103-112.
5. Vonesh EF, Snyder JJ, Foley RN, Collins AJ: Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int Suppl 2006;S3-S11.
6. Rasu RS, Crawford T, Manley HJ, Balkrishnan R: Treatment of hypertension and diabetes mellitus in patients with chronic kidney disease: A review. Expert Opin Pharmacother 2007; 8: 2543-2551.
7. Wiederkehr M, Toto R, Fenves AZ, Ram CV: Hypertension and the kidney. Semin Nephrol 2005; 25: 236-245.
8. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
9. Tomiyama C, Higa A, Dalboni MA, Cendoroglo M, Draibe SA, Cuppari L, Carvalho AB, Neto EM, Canziani ME: The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant 2006; 21: 2464-2471.
10. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538.
11. Wratten ML, Galaris D, Tetta C, Sevanian A: Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxid Redox Signal 2002; 4: 935-944.
12. Packer L, Cadenas E: Oxidants and antioxidants revisited. New concepts of oxidative stress. Free Radic Res 2007; 41: 951-952.
13. Shah SV, Baliga R, Rajapurkar M, Fonseca VA: Oxidants in chronic kidney disease. J Am Soc Nephrol 2007; 18: 16-28.
14. Shah S: Role of iron in progressive renal disease. Am J Kidney Dis 2001; 37:S30-S33.
15. Shah SV: Oxidants and iron in progressive kidney disease. J Ren Nutr 2006; 16: 185-189.
16. Himmelfarb J: Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin 2005; 23: 319-330.
17. Sachse A, Wolf G: Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol 2007; 18: 2439-2446.
18. Nankivell BJ, Boadle RA, Harris DC: Iron accumulation in human chronic renal disease. Am J Kidney Dis 1992; 20: 580-584.
19. Pryor WA: Oxidative stress status: OSS, BOSS, and 'Wild Bill' Donovan. Free Radic Biol Med 1999; 27: 1135-1136.
20. Salgo MG, Cueto R, Winston GW, Pryor WA: Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 1999; 26: 162-173.
21. Heinecke JW: Oxidative stress: New approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003; 91: 12A-16A.
22. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW: Myeloperoxidase- catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med 2001; 31: 1163-1169.
23. Heinecke JW: Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall. FASEB J 1999; 13: 1113-1120.
24. Mitrogianni Z, Barbouti A, Galaris D, Siamopoulos KC: Tyrosine nitration in plasma proteins from patients undergoing hemodialysis. Am J Kidney Dis 2004; 44: 286-292.
25. Miyata T, Kurokawa K, van Ypersele de Strihou C: Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int Suppl 2000; 76:S120-S125.
26. Miyata T, Ueda Y, Saito A, Kurokawa K: 'Carbonyl stress' and dialysis-related amyloidosis. Nephrol Dial Transplant 2000; 15(suppl 1):25-28.
27. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999; 55: 389-399.
28. KDOQI: Clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2007; 50: 471-530.
29. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-254.
30. Himmelfarb J: Linking oxidative stress and inflammation in kidney disease: Which is the chicken and which is the egg? Semin Dial 2004; 17: 449-454.
31. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis K, Tselepis A, Siamopoulos K, Tsakiris D: Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 2006; 48: 752-760.
32. Oberg BP, McMenamin E, Lucas FL, Mc-Monagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016.
33. Himmelfarb J, McMonagle E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001; 60: 358-363.
34. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, Otagiri M: Oxidation and carboxy methyl lysine-modification of albumin: Possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 2005; 28: 973-980.
35. Vanholder R, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Massy ZA, Rodriguez M, Stegmayr B, Stenvinkel P, Wratten ML: Uremic toxicity: Present state of the art. Int J Artif Organs 2001; 24: 695-725.
36. Anraku M, Kitamura K, Shinohara A, Adachi M, Suenga A, Maruyama T, Miyanaka K, Miyoshi T, Shiraishi N, Nonoguchi H, Otagiri M, Tomita K: Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int 2004; 66: 841-848.
37. Donate T, Herreros A, Martinez E, Martinez J, Andres E, Cabezas A, Ortiz A, de Prado A, Pou JM, Pamplona R, Portero OM, Bellmunt MJ: Protein oxidative stress in dialysis patients. Adv Perit Dial 2002; 18: 15-17.